Jin Medical International Ltd. Files 6-K Report
Ticker: ZJYL · Form: 6-K · Filed: Jul 26, 2024 · CIK: 1837821
| Field | Detail |
|---|---|
| Company | Jin Medical International Ltd. (ZJYL) |
| Form Type | 6-K |
| Filed Date | Jul 26, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, disclosure, foreign-private-issuer
Related Tickers: JMEI
TL;DR
Jin Medical Intl (JMEI) filed a 6-K on 7/26 for Q1 2024, reporting from China.
AI Summary
Jin Medical International Ltd. filed a Form 6-K on July 26, 2024, reporting as a foreign private issuer. The filing pertains to the period ending March 31, 2024, and provides information about the company's principal executive offices located in Changzhou City, Jiangsu Province, People's Republic of China.
Why It Matters
This filing provides an update on Jin Medical International Ltd.'s regulatory disclosures, which is important for investors tracking the company's compliance and reporting status.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- Jin Medical International Ltd. (company) — Registrant
- 001-41661 (company) — SEC File Number
- 20240726 (date) — Filing Date
- 20240331 (date) — Period of Report
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed by Jin Medical International Ltd. pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What period does this filing cover?
The Conformed Period of Report for this filing is March 31, 2024.
Where are Jin Medical International Ltd.'s principal executive offices located?
The principal executive offices are located at No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province, People's Republic of China.
Is Jin Medical International Ltd. required to file Form 20-F or Form 40-F annually?
Yes, the registrant indicates it files annual reports under cover of Form 20-F.
What is the SEC file number for Jin Medical International Ltd.?
The SEC file number for Jin Medical International Ltd. is 001-41661.
Filing Stats: 309 words · 1 min read · ~1 pages · Grade level 10.1 · Accepted 2024-07-26 16:10:22
Filing Documents
- ea0209844-6k_jinmedical.htm (6-K) — 18KB
- ea020984401ex99-1_jinmedical.htm (EX-99.1) — 697KB
- ea020984401ex99-2_jinmedical.htm (EX-99.2) — 170KB
- 0001013762-24-001595.txt ( ) — 6404KB
- zjyl-20240331.xsd (EX-101.SCH) — 79KB
- zjyl-20240331_cal.xml (EX-101.CAL) — 65KB
- zjyl-20240331_def.xml (EX-101.DEF) — 334KB
- zjyl-20240331_lab.xml (EX-101.LAB) — 558KB
- zjyl-20240331_pre.xml (EX-101.PRE) — 344KB
- ea0209844-6k_jinmedical_htm.xml (XML) — 799KB
Financial Statements and Exhibits
Financial Statements and Exhibits. Exhibits : Exhibit No. Description 99.1 Unaudited Condensed Consolidated Financial Statements as of March 31, 2024 and for the Six Months Ended March 31, 2024 and 2023. 99.2 Operating and Financial Review and Prospects in Connection with the Unaudited Condensed Consolidated Financial Statements for the Six Months March 31, 2024 and 2023. 101.INS Inline XBRL Instance Document 101.SCH Inline XBRL Taxonomy Extension Schema Document. 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document. 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document. 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document. 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Jin Medical International Ltd . Date: July 26, 2024 By: /s/ Erqi Wang Erqi Wang Chief Executive Officer By: /s/ Ziqiang Wang Ziqiang Wang Chief Financial Officer 2